학술논문

Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness.
Document Type
Article
Source
Ophthalmology. Mar2021, Vol. 128 Issue 3, p393-400. 8p.
Subject
*ANTIHYPERTENSIVE agents
*ACE inhibitors
*RETINAL ganglion cells
*ASIANS
*GANGLIA
*NERVE fibers
Language
ISSN
0161-6420
Abstract
To evaluate the association between different classes of antihypertensive medication with retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness in a nonglaucomatous multiethnic Asian population. Population-based, cross-sectional study. A total of 9144 eyes for RNFL analysis (2668 Malays, 3554 Indians, and 2922 Chinese) and 8549 eyes for GC-IPL analysis (2460 Malays, 3230 Indians, and 2859 Chinese) aged 44 to 86 years. Participants underwent standardized systemic and ocular examinations and interviewer-administered questionnaires for collection of data on medication and other variables. Intraocular pressure (IOP) readings were obtained by Goldmann applanation tonometry before pupil dilation for fundoscopy and OCT imaging. Blood pressure (BP) was measured with an automatic BP monitor. Mean arterial pressure (MAP) was defined as diastolic BP plus 1/3 (systolic BP – diastolic BP). Regression models were used to investigate the association of antihypertensive medication with OCT measurements of RNFL and GC-IPL. Average and sectoral RNFL and GC-IPL thickness. After adjusting for age, gender, ethnicity, MAP, IOP, body mass index (BMI), and presence of diabetes, we found that participants taking any type of antihypertensive medication (β = −0.83; 95% confidence interval [CI], −1.46 to −0.02; P = 0.01), specifically angiotensin-converting enzyme inhibitors (ACEIs) (β = −1.66; 95% CI, −2.57 to −0.75; P < 0.001) or diuretics (β = −1.38; 95% CI, −2.59 to −0.17; P < 0.05), had thinner average RNFL in comparison with participants who were not receiving antihypertensive treatment. Use of a greater number of antihypertensive medications was significantly associated with thinner average RNFL (P for trend = 0.001). This association was most evident in the inferior RNFL quadrant in participants using ACEIs (β = −2.44; 95% CI, −3.99 to −0.89; P = 0.002) or diuretics (β = −2.76; 95% CI, −4.76 to −0.76; P = 0.007). A similar trend was noted in our analysis of macular GC-IPL thickness. Use of 2 or more antihypertensive medications, ACEI, and diuretics were associated with a loss of structural markers of retinal ganglion cell health in a multiethnic Asian population. [ABSTRACT FROM AUTHOR]